Additional file 1: Table S1. of The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation
| Autor: | D. Lundon, A. Boland, M. Prencipe, G. Hurley, A O’Neill, E. Kay, S. Aherne, P. Doolan, S. Madden, M. Clynes, C. Morrissey, J. Fitzpatrick, R. Watson |
|---|---|
| Rok vydání: | 2017 |
| Předmět: | |
| DOI: | 10.6084/m9.figshare.c.3706762_d1 |
| Popis: | Characteristics of patient cohort and differences between Docetaxel naïve and Docetaxel resistant patients. N = 42. Values are presented as mean (standard deviation). * P-values |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|